AGA Finds No Clear Evidence for or Against AI-Assisted Colonoscopy
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 2, 2025 -- In a living clinical practice guideline issued by the American Gastroenterological Association and published in the April issue of Gastroenterology, no recommendation -- for or against -- is made for the use of computer-aided detection (CADe) systems for the detection of colorectal polyps during colonoscopy.
Shahnaz Sultan, M.D., from the University of Minnesota in Minneapolis, and colleagues conducted a systematic review to examine the desirable and undesirable effects of CADe-assisted colonoscopy and evaluated evidence assessing the values and preferences of patients undergoing colonoscopy.
The researchers note that no recommendation can be made for or against the use of CADe-assisted colonoscopy in light of very low certainty of evidence for the critical outcomes (desirable and undesirable), increased burden of more intensive surveillance colonoscopies, and cost and resource implications. The authors did find some evidence that CADe may lead to an 8 percent increase in adenoma detection rate, a 2 percent increase in the detection rate of advanced colorectal neoplasia, and a 1 percent increase in sessile serrated lesion detection rate.
"If artificial intelligence is going to be impactful, it needs to be better than the human eye," Sultan said in a statement. "Right now, artificial intelligence is detecting easy-to-detect lesions. This is version 1.0. Before we can recommend everyone use AI, we need version 4.0, where it helps detect polyps that are truly difficult to find."
Two authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.